|
advertisement
|
Company Overview: |
| Encysive Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. |
Products and Services: |
Encysive Pharmaceuticals have successfully developed one FDA-approved product, Argatroban, licensed to GlaxoSmithKline, and have a rich product pipeline.
Encysive Pharmaceuticals's lead drug candidate, THELIN® (sitaxentan sodium) was approved in August 2006 by the European Union. THELIN® is commercially available in the United Kingdom and Germany and is expected to become available in additional EU countries in 2007. Additionally, THELIN® is under regulatory review in the United States, Australia and Canada. |
|
|
|
|
Back to Top
|
|
Working @ Encysive Pharmaceuticals
Have your shout about working or interveiwing at Encysive Pharmaceuticals
1 message posted
Message Posted:
Working @ Encysive Pharmaceuticals
Share your experiences about working, interviewing or applying for a job at Encysive ...
Author: Obi Posted: 4/2/2007 8:40:49 AM |
View or add comments about Encysive Pharmaceuticals
Back to Top
|
Encysive Pharmaceuticals in the News
- Encysive Pharmaceuticals CFO Busenbark resigns (at MarketWatch)
Published: Monday, July 09, 2007
- Press Release: Encysive Pharmaceuticals to Cut Workforce, Replaces CEO
Published: Tuesday, June 26, 2007
- Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations (PrimeNewswire)
Published: Monday, June 25, 2007
- Encysive Pharmaceuticals Takes Another FDA Beating (Seeking Alpha)
Published: Sunday, June 17, 2007
- Encysive Pharmaceuticals Announces Launch of Thelin in Germany
Published: Tuesday, December 19, 2006
View more news about Encysive Pharmaceuticals
Back To Top |
|
|
|
|
Categories:
|
Biotechnology
|
|
Back to Top
|
|
|
|